Progestin-only contraception: injectables and implants.
作者： Roy Jacobstein , Chelsea B. Polis
DOI: 10.1016/J.BPOBGYN.2014.05.003
关键词:
摘要: Progestin-only contraceptive injectables and implants are highly effective, longer-acting methods that can be used by most women in circumstances. Globally, 6% of using modern contraception use 1% implants. Injectables the predominant method sub-Saharan Africa, account for 43% used. A lower-dose, subcutaneous formulation widely injectable, depot-medroxyprogesterone acetate, has been developed. Implants have highest effectiveness any method. Commodity cost, which historically limited implant availability low-resource countries, was markedly lowered between 2012 2013. Changes menstrual bleeding patterns extremely common with both methods, a main cause discontinuation. Advice from normative bodies differs on progestin-only breastfeeding 0–6 weeks postpartum. Whether these associated HIV acquisition is controversial issue, important implications disproportionate burden human immunodeficiency virus (HIV) maternal mortality.
bestpracticeobgyn.com
core.ac.uk 参考文章(82)
Christine Dehlendorf, Kira Levy, Allison Kelley, Kevin Grumbach, Jody Steinauer, Women's preferences for contraceptive counseling and decision making. Contraception. ,vol. 88, pp. 250- 256 ,(2013) , 10.1016/J.CONTRACEPTION.2012.10.012
James Trussell, Anjana M. Lalla, Quan V. Doan, Eileen Reyes, Lionel Pinto, Joseph Gricar, Cost effectiveness of contraceptives in the United States Contraception. ,vol. 79, pp. 5- 14 ,(2009) , 10.1016/J.CONTRACEPTION.2008.08.003
John Stanback, Fatimata Diabate, Thierno Dieng, Telma Duarte de Morales, Stirling Cummings, Mahamodou Traore, Ruling out pregnancy among family planning clients: the impact of a checklist in three countries. Studies in Family Planning. ,vol. 36, pp. 311- 315 ,(2005) , 10.1111/J.1728-4465.2005.00073.X
Anrudh K. Jain, Francis Obare, Saumya RamaRao, Ian Askew, Reducing unmet need by supporting women with met need International Perspectives on Sexual and Reproductive Health. ,vol. 39, pp. 133- 141 ,(2013) , 10.1363/3913313
Markus J. Steiner, Cynthia Kwok, John Stanback, Josaphat K. Byamugisha, Tsungai Chipato, Thulani Magwali, Francis Mmiro, Sungwal Rugpao, Somchai Sriplienchan, Charles Morrison, Injectable contraception: what should the longest interval be for reinjections? Contraception. ,vol. 77, pp. 410- 414 ,(2008) , 10.1016/J.CONTRACEPTION.2008.01.017
Gloria Bachmann, Paul Korner, Bleeding patterns associated with non-oral hormonal contraceptives: a review of the literature Contraception. ,vol. 79, pp. 247- 258 ,(2009) , 10.1016/J.CONTRACEPTION.2008.10.012
P.C. Schwallie, J.R. Assenzo, The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: A review Contraception. ,vol. 10, pp. 181- 202 ,(1974) , 10.1016/0010-7824(74)90073-0
H.T. Salem, M. Salah, M.Y. Aly, A.I. Thabet, M.M. Shaaban, M.F Fathalla, Acceptability of injectable contraceptives in Assiut, Egypt Contraception. ,vol. 38, pp. 697- 710 ,(1988) , 10.1016/0010-7824(88)90051-0
Holly M. Burke, Monique P. Mueller, Catherine Packer, Brian Perry, Leonard Bufumbo, Daouda Mbengue, Bocar Mamadou Daff, Anthony Mbonye, Provider acceptability of Sayana Press: results from community health workers and clinic-based providers in Uganda and Senegal. Contraception. ,vol. 89, pp. 368- 373 ,(2014) , 10.1016/J.CONTRACEPTION.2014.01.009
Chelsea B. Polis, Daniel Westreich, Jennifer E. Balkus, Renee Heffron, Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches AIDS. ,vol. 27, ,(2013) , 10.1097/QAD.0000000000000036